The canonical IFN-γ/JAK/STAT pathway.

Slides:



Advertisements
Similar presentations
CYTOKINES AND RECEPTORS Chapter 12. What Is A Cytokine? Low molecular weight proteins (30 KDa) Bind receptors, alter gene expression Can bind the secreting.
Advertisements

IGF in circulation The majority (> 75 %) exists as bound form –IGF binding proteins (IGFBPs) IGFBPs –6 proteins and several related proteins –Serum IGFBP.
 Binding sites for several key transcription factors, including nuclear factor (NF)-kB and various interferon regulatory factor (IRF) proteins, are present.
Extracellular signal molecule
Caffeine Signaling via Ligand-Receptor Binding Agonist - ligand binding to a receptor and eliciting a response Antagonist - ligand binding to a receptor.
JAK-STAT Signaling Pathway.
CYTOKINES AND RECEPTORS DR SANJITA DAS. What Is A Cytokine? Low molecular weight proteins (30 KDa) Bind receptors, alter gene expression Can bind the.
Nonconventional Initiation Complex Assembly by STAT and NF-κB Transcription Factors Regulates Nitric Oxide Synthase Expression Matthias Farlik, Benjamin.
Biomembrane and Cell signalling BCH 452(V) Cell To Cell Comunication
Leptin receptor functions: When leptin binds to its receptor (LEPR-B) the receptor undergoes a conformational change that activates the receptor-associated.
The JAK-STAT signal-transduction pathway
OVERVIEW: Signals for cell surface receptors (hydrophilic):
Type I Interferon Signal Pathway. InterferonInterferon (IFNs) is a group of signaling proteins made and released by host cells in response to the presence.
Sustaining Proliferative Signaling and Evading Growth Suppressors
Nat. Rev. Rheumatol. doi: /nrrheum
Chap. 16 Problem 1 Cytokine receptors and RTKs both form functional dimers on binding of ligand. Ligand binding activates cytosolic kinase domains which.
TGFb –Superfamily Proteins
Laurent L'homme, PhD, David Dombrowicz, PhD 
Volume 52, Issue 3, Pages (March 2010)
IRS-1: Auditing the effectiveness of mTOR inhibitors
RNA interference in biology and disease
Figure 5 Defects in the JAK–STAT signalling pathway
Volume 98, Issue 4, Pages (February 2010)
Cell to Cell Communication via Enzyme Linked Receptors
Biology of common β receptor–signaling cytokines
Mechanism of action of a transcription factor decoy to STAT3.
Michael K. Badman, Jeffrey S. Flier  Gastroenterology 
Figure 1 Overview of canonical TGF-β/Smad signalling in tissue fibrosis Figure 1 | Overview of canonical TGF-β/Smad signalling in tissue fibrosis. Once.
دکتر مجیری داروساز متخصص فارماکولوژی
Nat. Rev. Rheumatol. doi: /nrrheum
LPS induces CD40 gene expression through the activation of NF-κB and STAT-1α in macrophages and microglia by Hongwei Qin, Cynthia A. Wilson, Sun Jung Lee,
Development of PI3K/AKT/mTOR Pathway Inhibitors and Their Application in Personalized Therapy for Non–Small-Cell Lung Cancer  Vassiliki Papadimitrakopoulou,
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
MCB Exam 2 Review 11/3/2018.
Figure 3 Inhibitors of the IL-6/JAK/STAT3 signalling pathway
Interferon-α and -β in kidney inflammation
Connecting Mitochondria and Innate Immunity
Bin Gao, Hua Wang, Fouad Lafdil, Dechun Feng  Journal of Hepatology 
Volume 18, Issue 1, Pages (July 2013)
Calcium Signaling: Deciphering the Calcium–NFAT Pathway
Pathogenesis of Flavivirus Infections: Using and Abusing the Host Cell
Interleukin-6 participation in pathology of ocular diseases
JAK/STAT Signalling: STAT Cannot Play with Ken and Barbie
SRC and STAT Pathways Journal of Thoracic Oncology
Volume 123, Issue 6, Pages (December 2002)
SOCS Proteins, Regulators of Intracellular Signaling
Manfred Fliegauf, PhD, Bodo Grimbacher, MD 
Schematic summary of the mechanisms by which tick-borne Phlebovirus NSs proteins inhibit the canonical IFN induction and signaling pathways. Schematic.
Michael K. Badman, Jeffrey S. Flier  Gastroenterology 
Genetic Control of MHC Class II Expression
Mechanism-Based Precision Therapy for the Treatment of Primary Immunodeficiency and Primary Immunodysregulatory Diseases  Jennifer W. Leiding, MD, Lisa.
Nat. Rev. Urol. doi: /nrurol
Chapter 16 Cell Communication.
IL-13 receptors and signaling pathways: An evolving web
Shared Principles in NF-κB Signaling
(A) The canonical Smad pathway.
Primary immunodeficiencies may reveal potential infectious diseases associated with immune-targeting mAb treatments  László Maródi, MD, PhD, Jean-Laurent.
Fig. 3 Conditionally expressed CAR using Notch as a signal induction and response pathway system. Conditionally expressed CAR using Notch as a signal induction.
Figure 2 Signalling downstream of the IL-6 receptor
The mitogen-activated protein kinase (MAPK) pathway showing mutations identified in pulmonary Langerhans cell histiocytosis (PLCH). The mitogen-activated.
Cross-regulation of Signaling Pathways by Interferon-γ: Implications for Immune Responses and Autoimmune Diseases  Xiaoyu Hu, Lionel B. Ivashkiv  Immunity 
Volume 7, Issue 1, Pages 1-11 (July 1997)
Figure 5 TLR-dependent signaling pathways inhibited by glatiramer acetate Myeloid differentiation primary response gene 88 (MyD88) and Toll-IL-1 receptor.
Nat. Rev. Urol. doi: /nrurol
Yang Cang-Jin , Zhang Chi , Lu Yang-Ning , Jin Jia-Qi , Wang Xue-Lu  
TYK2 signaling in T-ALL. TYK2 signaling in T-ALL. TYK2 activates STAT1 through phosphorylation downstream of the IL-10 receptor. Once phosphorylated, STAT.
Schematic demonstration of hedgehog signal pathway.
Model of immunosuppressive drug action in lymphocyte activation.
Successful targeting of ErbB2 receptors—is PTEN the key?
Overview of molecular JAK signaling.
Presentation transcript:

The canonical IFN-γ/JAK/STAT pathway. The canonical IFN-γ/JAK/STAT pathway. Binding of IFN-γ dimers to the extracellular domain of the IFN-γR1 receptor subunit leads to engagement of the IFN-γR2 subunit, which causes JAK1 and JAK2 to cross-phosphorylate each other and the receptor subunits. The parallel STAT1 homodimers are then recruited to the receptors, and their phosphorylation converts the homodimers into an antiparallel configuration. The reoriented STAT1 homodimers translocate to the nucleus, where they bind to GAS sites on the primary response genes, including IRF1. IRF1 subsequently activates a large number of secondary response genes, which carry out a range of immunomodulatory functions. The SOCS proteins serve as the major negative regulators of the IFN-γ pathway by inhibiting the phosphorylation of JAKs and STAT1. Dephosphorylation and acetylation of STAT1 homodimers revert them to parallel configuration and cause their exit from the nucleus. HAT, histone acetyltransferase. M. Raza Zaidi, and Glenn Merlino Clin Cancer Res 2011;17:6118-6124 ©2011 by American Association for Cancer Research